PROGRAM
 





Scientific Program

> PROGRAM > SCIENTIFIC PROGRAM




* As of March 2018

Day 1, April 5 (Thu) Day 2, April 6 (Fri) Day 3, April 7 (Sat)

Symposium 1 : Cutting-edge Technology to Support Decision Making in Breast Cancer Treatment
Date & Time Day 1, Apr 5(Thu), 09:15-10:45 Venue 2F, Premier Ballroom AB
Moderators
Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong)
Wonshik Han (Seoul National Univ. Hospital, Korea)
Speakers
Liquid Biopsy: CTC, CTDNA, Exosome etc.
Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong)
Clinical Utility of Multigene Assays in Breast Cancer
Woo-Chan Park (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Artificial Intelligence in Treatment of Breast Cancer Patients: Need of the Day: Role of AI Watson for Oncology
Somashekhar S. P. (Manipal Comprehensive Cancer Center, India)

Panel Discussion 1 : How to Treat Good Responders to Neoadjuvant Chemotherapy
Date & Time Day 1, Apr 5(Thu), 09:15-10:45 Venue 2F, Premier Ballroom C
Moderators
Stephen Grobmyer (Cleveland Clinic, U.S.A.)
Gyungyub Gong (ASAN Medical Center, Korea)
Speakers
Can We Omit Surgery with Suggestion of pCR by Biopsy in the Breast?
Keda Yu (Shanghai Cancer Center and Cancer Institute, Fudan Univ., China)
Evaluation of Axillary LNs after Neoadjuvant Systemic Therapy
Min Jung Kim (Yonsei Univ. Severance Hospital, Korea)
Evaluation of Pathologic Response in Breast Cancer Treated with Primary Systemic Therapy
Eun Yoon Cho (Samsung Medical Center, Korea)
Radiation Therapy for Patients with pCR after Neoadjuvant Chemotherapy
Won Park (Samsung Medical Center, Korea)

Education Session 1 : New Techniques and Technology in Breast Screening
Date & Time Day 1, Apr 5(Thu), 09:15-10:45 Venue 1F, 107-109
Moderators
Janice Sung (Memorial Sloan Kettering Cancer Center, U.S.A.)
Boo-Kyung Han (Samsung Medical Center, Korea)
Speakers
New Techniques and Technology in Breast Screening Including Contrast Enhanced Mammography
Janice Sung (Memorial Sloan Kettering Cancer Center, U.S.A.)
Automated Breast US as Supplemental Screening Modality in Women with Dense Breasts
Sung Hun Kim (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
Abbreviated Breast MRI for High-Risk Breast Cancer Screening
Woo Kyung Moon (Seoul National Univ. Hospital, Korea)

Oral Presentation 1 : Oral Presentation 1
Date & Time Day 1, Apr 5(Thu), 09:15-10:45 Venue 1F, 104-106
Moderators
Je-Ryong Kim (Chungnam National Univ. Hospital, Korea)
Dae-Sung Yoon (Konyang Univ. Hospital, Korea)
Speakers
DEAD-BOX RNA HELICASE DP103 ENHANCES YAP SUMOYLATION FOR YAP-TEAD DEPENDENCE AND STATIN SENSITIVITY IN TRIPLE NEGATIVE BREAST CANCER
Alan Prem Kumar (National Univ. of Singapore, Singapore)
RESVERATROL SUPPRESSES BREAST CANCER PROLIFERATION THROUGH INHIBITION OF STAT3 ACTIVATION AND M2-MACROPHAGE POLARIZATION
Isabella Wai Yin Cheuk (The Univ. of Hong Kong, Hong Kong)
ESTROGEN RECEPTOR POSITIVE IS NOT ENOUGH TO PREDICT THE PROGNOSIS OF BREAST CANCER
Jai Min Ryu (Samsung Medical Center, Korea)
CLINICOPATHOLOGICAL FACTORS AFFECTING DISTANT METASTASIS IN LOCOREGIONAL RECURRENCE OF BREAST CANCER
Cheol Min Kang (ASAN Medical Center, Korea)
ULTRASOUND-GUIDED RESTAGING AND LOCALIZATION OF AXILLARY LYMPH NODES AFTER NEOADJUVANT CHEMOTHERAPY FOR GUIDANCE OF AXILLARY SURGERY IN BREAST CANCER PATIENTS: EXPERIENCE WITH ACTIVATED CHARCOAL
Won Hwa Kim (Kyungpook National Univ. Hospital, Korea)
APPLICATION OF ROBOTIC SURGERY (DA VINCI) IN THE MANAGEMENT OF BREAST CANCER- PRELIMINARY RESULTS AND EXPERIENCE SHARING
Hung-Wen Lai (Changhua Christian Hospital, Taiwan)
CHARACTERIZATION OF THE MICROBIOME OF BREAST TISSUE AND GUT IN KOREAN BREAST CANCER PATIENTS
Nam Won Kim (Soonchunhyang Univ. Hospital, Seoul, Korea)
PREDICTING THE RISK OF PERIPHERAL NEUROPATHY BY THE COMBINATION OF FOUR SERUM MICRORNAS
Shoko Narita (National Cancer Center Hospital, Japan)

Plenary Lecture 1 : Overview of Therapeutic Strategies for Early Breast Cancer Patients: Past, Present and Future
Date & Time Day 1, Apr 5(Thu), 10:45-11:45 Venue 2F, Premier Ballroom AB
Moderators
Woochul Noh (Korea Cancer Center Hospital, Korea)
Speakers
Overview of Therapeutic Strategies for Early Breast Cancer Patients: Past, Present and Future
Eric P. Winer (Dana-Farber Cancer Institute, U.S.A.)

Satellite Symposium 1 : Ethnic Differences in the Treatment Landscape of Breast Cancer: Western vs. Asian
Date & Time Day 1, Apr 5(Thu), 12:00-12:45 Venue 2F, Premier Ballroom AB
Moderators
Dong-young Noh (Seoul National Univ. Hospital, Korea)
Speakers
Ethnic Differences in the Treatment Landscape of Breast Cancer: Western vs. Asian
Louis Chow (Organisation for Oncology and Translational Research, Hong Kong)

Plenary Lecture 2 : Application of the Concept of Intrinsic Subtypes to Clinical Decision Making
Date & Time Day 1, Apr 5(Thu), 13:15-14:15 Venue 2F, Premier Ballroom AB
Moderators
Young-Hyuck Im (Samsung Medical Center, Korea)
Speakers
Application of the Concept of Intrinsic Subtypes to Clinical Decision Making
Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.)

Symposium 2 : Overcoming Resistance to HER2-directed Therapies
Date & Time Day 1, Apr 5(Thu), 14:30-16:00 Venue 2F, Premier Ballroom AB
Moderators
Ian Krop (Dana-Farber Cancer Institute, U.S.A.)
Jung Sil Ro (National Cancer Center, Korea)
Speakers
Heterogeneity of HER2: Mutation, Amplification, Expression and Clinical Implications
So Yeon Park (Seoul National Univ. Bundang Hospital, Korea)
Biomarkers for HER2-directed Therapies : Past Failure and Future Perspectives
Ian Krop (Dana-Farber Cancer Institute, U.S.A.)
Evolving Strategies to Overcome Resistance to HER2 Targeted Agents
Sung-Bae Kim (ASAN Medical Center, Korea)

Panel Discussion 2 : Issues with Mastectomy and Reconstruction
Date & Time Day 1, Apr 5(Thu), 14:30-16:00 Venue 2F, Premier Ballroom C
Moderators
Hak Chang (Seoul National Univ. Hospital, Korea)
Ho Yong Park (Kyungpook National Univ. Chilgok Hospital, Korea)
Speakers
How to Make a Good Mastectomy for Reconstruction Based on the Anatomy
Jin Zhang (Tianjin Medical Univ. Cancer Institute & Hospital, China)
Reconstruction with Autologous Tissue
David Chang (Univ. of Chicago, U.S.A.)
Reconstruction with Implant
Hak Chang (Seoul National Univ. Hospital, Korea)

Education Session 2 : Healthy Living after Breast Cancer Treatment
Date & Time Day 1, Apr 5(Thu), 14:30-16:00 Venue 1F, 107-109
Moderators
Louis Chow (Organisation for Oncology and Translational Research, Hong Kong)
Sung Hoo Jung (Chonbuk National Univ. Hospital, Korea)
Speakers
Addressing Relationships Following a Breast Cancer Diagnosis: The Impact on Partners, Children and Caregivers
Shoshana M Rosenberg (Dana-Farber Cancer Institute, U.S.A.)
The Effect of Exercise Recommendation on the Level of Physical Activity in Breast Cancer
Justin Jeon (Yonsei Univ., Korea)
Heart Disease in Breast Cancer Survivors
Jihyoun Lee (Soonchunhyang Univ. Hospital, Seoul, Korea)

Invited Oral Presentation : Invited Oral Presentation
Date & Time Day 1, Apr 5(Thu), 14:30-16:00 Venue 1F, 104-106
Moderators
Se-Jeong Oh (The Catholic Univ. of Korea, Incheon St. Mary's Hospital, Korea)
Yongsik Jung (Ajou Univ. Hospital, Korea)
Speakers
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery
Taein Yoon (Dongnam Inst. of Radiological & Medical Sciences, Korea)
Imaging Biomarker for Molecular Oncology: Focusing on HER2 Evaluation
Ilhan Lim (Korea Cancer Center Hospital, Korea)
A Phase II Trial of Pan-HER Inhibitor Poziotinib, in Patients with HER2-Positive Metastatic Breast Cancer Who Have Received at Least Two Prior HER2 Therapies
Yeon Hee Park (Samsung Medical Center, Korea)
Ribociclib Plus Goserelin and Tamoxifen or a Non-steroidal Aromatase Inhibitor (NSAI) for Premenopausal Women with Hormone Receptor-positive (HR+), Human Epidermal Growth Factor Receptor 2-negative (HER2–) Advanced Breast Cancer (ABC) in the Randomized Phase III MONALEESA-7 Trial
Seock-Ah Im (Seoul National Univ. Hospital, Korea)
Different Prognosis of Young Breast Cancer Patients in Their 20s and 30s Depending on Subtype: A Nationwide Study from the Korean Breast Cancer Society
Seok Won Kim (Samsung Medical Center, Korea)

Symposium 3 : Breakthrough in Triple Negative Breast Cancer
Date & Time Day 1, Apr 5(Thu), 16:15-17:45 Venue 2F, Premier Ballroom AB
Moderators
Funda Meric-Bernstam (The Univ. of Texas MD Anderson Cancer Center, U.S.A.)
Woochul Noh (Korea Cancer Center Hospital, Korea)
Speakers
Current Approaches in Treatment of TNBC
Soo Chin Lee (National Univ. Cancer Institute, Singapore)
PARP Inhibitors and DNA Repair
Seock-Ah Im (Seoul National Univ. Hospital, Korea)
Novel Targets and Overview of Ongoing Clinical Trials
Funda Meric-Bernstam (The Univ. of Texas MD Anderson Cancer Center, U.S.A.)

Panel Discussion 3 : NGS in the Era of Personalized Therapy: A Valuable Compass or a Valueless Noise?
Date & Time Day 1, Apr 5(Thu), 16:15-17:45 Venue 2F, Premier Ballroom C
Moderators
Charles M. Perou (Univ. of North Carolina at Chapel Hill, U.S.A.)
Woong-Yang Park (Samsung Medical Center, Korea)
Speakers
International Guidelines for the Use of NGS Panels
Yang Wen-Tao (Fudan Univ., China)
Biomarker Driven Cancer Therapy by Multiple NGS Panels for Somatic Mutations
Woong-Yang Park (Samsung Medical Center, Korea)
Application of Multiple NGS Panels for Germline Variation to Real Practice
Ji Soo Park (Yonsei Cancer Center, Korea)

Education Session 3 : State of the Art of the Lymphedema Treatment
Date & Time Day 1, Apr 5(Thu), 16:15-17:45 Venue 1F, 107-109
Moderators
David Chang (Univ. of Chicago, U.S.A.)
Young Up Cho (Yonsei Cancer Center, Korea)
Speakers
Appropriate Concept of Prevention of Lymphedema at the Initial Treatment
Zisun Kim (Soonchunhyang Univ. Hospital, Bucheon, Korea)
Early-stage Lymphedema Detection and Conservative Treatment
Eun Joo Yang (Seoul National Univ. Bundang Hospital, Korea)
Surgical Treatment Options for Advanced Lymphedema
Jung-Ju Huang (Chang Gung Memorial Hospital, Taiwan)

Survivorship Session 1 : Building up Evidences for Breast Cancer Survivorship Care in Precision Medicine Era
Date & Time Day 1, Apr 5(Thu), 16:15-17:45 Venue 1F, 104-106
Moderators
Isabelle Soerjomataram (International Agency for Research on Cancer, France)
Min-Hyuk Lee (Soonchunhyang Univ. Hospital, Seoul, Korea)
Speakers
The Reality in the Follow-up of Breast Cancer Survivors
Hyun Jo Youn (Chonbuk National Univ. Hospital, Korea)
Comprehensive Analysis of National Health Insurance Data for Breast Cancer Survivorship
Ho Hur (National Health Insurance Service Ilsan Hospital, Korea)
Benchmarking Breast Cancer Survival: International Collaborative Research Platform to Improve Patients Outcome
Isabelle Soerjomataram (International Agency for Research on Cancer, France)